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BACKGROUND
Whether conservative management is an acceptable alternative to interventional man-
agement for uncomplicated, moderate-to-large primary spontaneous pneumothorax is 
unknown.
METHODS
In this open-label, multicenter, noninferiority trial, we recruited patients 14 to 50 years 
of age with a first-known, unilateral, moderate-to-large primary spontaneous pneumo-
thorax. Patients were randomly assigned to immediate interventional manage-
ment of the pneumothorax (intervention group) or a conservative observational 
approach (conservative-management group) and were followed for 12 months. 
The primary outcome was lung reexpansion within 8 weeks.
RESULTS
A total of 316 patients underwent randomization (154 patients to the interven-
tion group and 162 to the conservative-management group). In the conservative-
management group, 25 patients (15.4%) underwent interventions to manage the 
pneumothorax, for reasons prespecified in the protocol, and 137 (84.6%) did not 
undergo interventions. In a complete-case analysis in which data were not available 
for 23 patients in the intervention group and 37 in the conservative-management 
group, reexpansion within 8 weeks occurred in 129 of 131 patients (98.5%) with in-
terventional management and in 118 of 125 (94.4%) with conservative management 
(risk difference, −4.1 percentage points; 95% confidence interval [CI], −8.6 to 0.5; 
P = 0.02 for noninferiority); the lower boundary of the 95% confidence interval was 
within the prespecified noninferiority margin of −9 percentage points. In a sensitiv-
ity analysis in which all missing data after 56 days were imputed as treatment failure 
(with reexpansion in 129 of 138 patients [93.5%] in the intervention group and in 118 
of 143 [82.5%] in the conservative-management group), the risk difference of −11.0 
percentage points (95% CI, −18.4 to −3.5) was outside the prespecified noninferiority 
margin. Conservative management resulted in a lower risk of serious adverse events 
or pneumothorax recurrence than interventional management.
CONCLUSIONS
Although the primary outcome was not statistically robust to conservative assumptions 
about missing data, the trial provides modest evidence that conservative management 
of primary spontaneous pneumothorax was noninferior to interventional man-
agement, with a lower risk of serious adverse events. (Funded by the Emergency 
Medicine Foundation and others; PSP Australian New Zealand Clinical Trials Regis-
try number, ACTRN12611000184976.)
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The annual rate of hospitalization for spontaneous pneumothorax among persons 15 years of age or older in Eng-
land is approximately 140 per million.1 One 
third of cases are primary, with no known 
previous pneumothorax or clinically apparent 
underlying lung disease.1,2 There is considerable 
heterogeneity in the management of primary 
spontaneous pneumothorax,3-5 but the most com-
mon treatment is interventional drainage, some-
times progressing to surgical intervention. How-
ever, the insertion of a chest tube is often painful6,7 
and can cause organ injury, bleeding, and in-
fection.8 Insertion of a chest tube often involves 
hospitalization, with a reported mean length of 
stay of 4 days in patients with a first presenta-
tion with spontaneous pneumothorax.9-11 Surgery, 
if the air leak continues, has additional risks, 
complications, and costs.11-13
An alternative approach is conservative man-
agement, with intervention reserved for patients 
for whom the pneumothorax becomes physio-
logically significant.14 Conservative management 
is supported by evidence from a historical cohort 
study15; however, there are not directive data from 
randomized, controlled trials that have compared 
conservative with interventional management16 
to determine their relative benefits and risks. 
We hypothesized that conservative management 
could be an effective and acceptable therapeutic 
option, with a similar percentage of patients 
with full lung reexpansion within 8 weeks as 
compared with interventional management, as 
well as a shorter length of hospital stay, fewer 
interventions and associated complications, and 
a lower risk of pneumothorax recurrence.
Me thods
Trial Design and Oversight
The Primary Spontaneous Pneumothorax (PSP) 
trial was a multicenter, prospective, randomized, 
open-label, noninferiority trial that was con-
ducted at 39 metropolitan and rural hospitals 
in Australia and New Zealand. The protocol 
was approved by national and state ethics com-
mittees and was published previously.17 The sta-
tistical analysis plan was published online18; the 
protocol and statistical analysis plan are avail-
able with the full text of this article at NEJM 
.org. All the patients provided written informed 
consent.
Patients 14 to 50 years of age were eligible 
for the trial if they had a unilateral (i.e., in one 
lung) primary spontaneous pneumothorax of 
32% or more on chest radiography according to 
the Collins method (sum of interpleural dis-
tances, >6 cm).19 (Details regarding the Collins 
method and the calculation of pneumothorax 
size are provided in Figs. S1 and S2 in the Sup-
plementary Appendix, available at NEJM.org.) 
Full exclusion criteria are listed in the Supple-
mentary Appendix.
Randomization
Patients were randomly assigned in a 1:1 ratio 
to either interventional management of the pneu-
mothorax (intervention group) or conservative 
management (conservative-management group), 
with stratification according to trial site; ran-
domization was performed with the use of an 
adaptive biased-coin (urn) technique.20 The Uni-
versity of Western Australia hosted a Web-based 
randomization system (FileMaker Server Ad-
vanced). The nature of the randomized treatment 
approaches meant that the trial-group assign-
ments were not masked to all the patients and 
the clinicians involved in their care.
Trial Treatments
All the patients received standard care with an-
algesia (acetaminophen, ibuprofen, and oral or 
intravenous opioids) as needed and oxygen supple-
mentation if oxygen saturation as measured by 
pulse oximetry (Spo2) was less than 92% while 
the patient was breathing ambient air.
Intervention Group
A small-bore (≤12 French) Seldinger-style chest 
tube was inserted and attached to an underwater 
seal, without suction. A chest radiograph was 
obtained 1 hour later. If the lung had reexpand-
ed and the underwater drain no longer bubbled, 
the drain was closed with the use of a three-
way stopcock. Four hours later, if the patient’s 
condition was stable and a repeat chest radio-
graph showed that the pneumothorax had not 
recurred, the drain was removed and the pa-
tient was discharged. If the initial drain inser-
tion did not result in resolution on radiography 
(often called radiographic resolution) or if the 
pneumothorax recurred under observation, the 
stopcock was opened, the underwater seal drain-
age was recommenced, and the patient was ad-
A Quick Take is 
available at 
NEJM.org 
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mitted to the hospital. Subsequent interventions 
were at the discretion of the attending clinicians.
Conservative-Management Group
Patients were observed for a minimum of 4 hours 
before a repeat chest radiograph was obtained. 
After observation, if patients did not receive 
supplementary oxygen and were walking com-
fortably, they were discharged with analgesia 
and written instructions. Interventions were al-
lowed in the conservative-management protocol 
under the following conditions: clinically signifi-
cant symptoms persisted despite adequate analge-
sia; chest pain or dyspnea prevented mobilization; 
a patient was unwilling to continue with con-
servative treatment; the patient’s condition be-
came physiologically unstable (systolic blood 
pressure of <90 mm Hg, heart rate in beats per 
minute greater than or equal to systolic blood 
pressure in millimeters of mercury, respiratory 
rate of >30 breaths per minute, or Spo2 of <90% 
while the patient was breathing ambient air); or 
a repeat chest radiograph showed an enlarging 
pneumothorax along with physiological insta-
bility. In these situations, subsequent interven-
tions were at the discretion of the attending 
clinicians.
Follow-up Assessments
All the patients had an in-person, unmasked 
clinical assessment between 24 and 72 hours 
after randomization and were assessed again at 
2-week, 4-week, and 8-week follow-up visits. 
These visits included a chest radiograph (if the 
pneumothorax had not resolved on the previous 
radiograph) and a structured questionnaire re-
garding symptoms, analgesia use, and patient 
satisfaction. Pneumothorax recurrence was as-
sessed 6 and 12 months after randomization by 
telephone calls to the patients and by clinical-
record searches.
Outcomes
The primary noninferiority outcome was com-
plete radiographic resolution of primary spon-
taneous pneumothorax (full lung reexpansion), 
as determined by the treating physician, within 
8 weeks after randomization. Data on patients 
in whom the 8-week visit occurred after 56 days 
were treated as missing, unless a later chest 
radiograph showed a persisting pneumothorax, 
thereby confirming treatment failure. Two sen-
sitivity analyses were undertaken: in one analy-
sis, the 8-week window was extended to 63 days 
and data on patients in whom the 8-week visit 
occurred after 63 days were treated as missing, 
unless a later chest radiograph showed a persist-
ing pneumothorax, thereby confirming treatment 
failure; in the other analysis, data on patients 
in whom the 8-week clinic visit occurred after 
56 days were imputed as failure.
Secondary outcomes included a per-protocol 
analysis of the primary outcome; complete lung 
reexpansion within 8 weeks, as reviewed by two 
radiologists who were unaware of the trial-group 
assignments; the time until complete resolution 
of symptoms, defined as no pain and no anal-
gesia use; pneumothorax recurrence, defined 
as an ipsilateral pneumothorax after a previous 
chest radiograph had confirmed complete reso-
lution 24 hours or more after removal of all chest 
tubes; adverse events; serious adverse events; the 
length of hospital stay in the first 8 weeks; the 
number of invasive procedures and radiologic 
investigations; the number of days off from work; 
persistent air leak, defined as chest-tube drain-
age for 72 hours or more; and patient satisfac-
tion, measured as a response to the question 
“How satisfied or dissatisfied are you with the 
results of treatment for your pneumothorax over-
all?” on a six-point Likert scale: very dissatis-
fied, dissatisfied, slightly dissatisfied, slightly 
satisfied, satisfied, or very satisfied.
Statistical Analysis
A sample of 274 patients was required to detect 
an absolute noninferiority margin of −9 per-
centage points, under the assumption of resolu-
tion of the pneumothorax by 8 weeks in 99% of 
the patients in the intervention group (one-sided 
alpha level of 5% and power of 95%). Noninferi-
ority was tested by generating a two-sided 95% 
confidence interval and using the lower 2.5% tail 
to compare the observed data. In the absence of 
any previously established noninferiority margin, 
the steering committee of respiratory and emer-
gency physicians reasoned that a success rate of 
90% in the conservative-management group as 
compared with an anticipated 99% success rate 
in the intervention group after 8 weeks would 
be acceptable to both doctors and patients. Al-
lowing for a 20% dropout rate, we planned to 
recruit up to 342 patients.
The primary analysis was based on logistic 
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regression of complete cases at 8 weeks. Esti-
mation of percentage points and absolute risk 
differences together with a binomial noninferi-
ority test were used for the primary outcome. 
The original statistical analysis plan did not 
specify the window for the 8-week visit nor define 
how missing radiographic data were to be han-
dled for the primary outcome. These issues were 
recognized post hoc to be important, because 
the intent of the trial was to establish whether 
there was resolution at the time of the 8-week 
visit. This goal was addressed by treating data 
on the primary outcome as missing in patients 
in whom the 8-week visit occurred after 56 days 
and by undertaking two sensitivity analyses to 
help determine the effects of informative cen-
soring and treating of missing data as treat-
ment failure.
Other categorical variables were analyzed by 
estimation of absolute risk differences and rela-
tive risks and a two-sided test. Count variables 
were analyzed by estimation of relative rates. 
Kaplan–Meier curves and a Cox proportional-
hazards estimate of the hazard ratio were used 
for the time until radiographic resolution, the 
time until symptom resolution, and the time 
until ipsilateral pneumothorax recurrence. Or-
dinal regression was used for the Likert-scaled 
satisfaction ratings. Logistic regression was used 
to assess subgroup effects. SAS software, ver-
sion 9.4, was used for all analyses.
R esult s
Patients
From July 2011 through March 2017, a total of 
316 patients underwent randomization (154 pa-
tients to the intervention group and 162 to the 
conservative-management group) (Fig. 1). The 
baseline characteristics of the patients are shown 
in Table 1 and Table S1. In the conservative-
management group, 137 of 162 patients (84.6%) 
did not undergo any intervention, but 25 patients 
(15.4%) did, with reasons shown in Table S2. In 
the intervention group, 10 patients (6.5%) de-
clined any intervention, and their care was man-
aged conservatively. There were 16 patients (5 in 
the intervention group and 11 in the conserva-
tive-management group) in which the 8-week 
assessments occurred between 56 and 63 days; 
in 6 additional patients (1 in the intervention 
group and 5 in the conservative-management 
group), the 8-week assessment was conducted 
after 9 weeks (Fig. S3).
Primary Outcome
In the complete-case analysis, in which data 
were treated as missing in patients if the 
8-week visit occurred after 56 days, 129 of 131 
(98.5%) in the intervention group had resolution 
within 8 weeks, as compared with 118 of 125 
(94.4%) in the conservative-management group 
(risk difference, −4.1 percentage points; 95% 
confidence interval [CI], −8.6 to 0.5; P = 0.02 for 
noninferiority); the lower boundary of the 95% 
confidence interval was within the noninferior-
ity margin of −9 percentage points. In the 
sensitivity analyses, noninferiority for resolu-
tion was maintained when the 8-week clinic 
visit was extended to 63 days (134 of 136 pa-
tients [98.5%] in the intervention group and 
129 of 136 [94.9%] in the conservative-manage-
ment group) (risk difference, −3.7 percentage 
points; 95% CI, −7.9 to 0.6) but not when the 
missing data after 56 days were imputed as 
failure (129 of 138 patients [93.5%] in the in-
tervention group and 118 of 143 [82.5%] in the 
conservative-management group) (risk difference, 
−11.0 percentage points; 95% CI, −18.4 to −3.5).
Secondary Outcomes
Radiographic Resolution
The median time until radiographic resolution 
was 16 days (interquartile range, 12 to 26) in the 
intervention group and 30 days (interquartile 
range, 25 to 54) in the conservative-management 
group (hazard ratio, 0.49; 95% CI, 0.39 to 0.63) 
(Fig. S4). There were 10 patients who were as-
signed to interventional management who de-
clined the intervention, and in the per-protocol 
analysis, 124 of 126 patients (98.4%) in the in-
tervention group had resolution within 8 weeks 
as compared with 123 of 130 patients (94.6%) in 
the conservative-management group (risk differ-
ence, −3.8 percentage points; 95% CI, −8.3 to 
0.7). Radiologists were more likely than treat-
ing clinicians to assess a radiograph obtained 
at the 8-week visit as not showing resolution, 
with a risk difference of −5.9 percentage points 
(95% CI, −8.8 to −2.9) (Table S3). For the pa-
tients in whom the radiograph obtained at the 
8-week visit was available to the radiologists, 
the radiologists who were unaware of the trial-
group assignments assessed 114 of 124 patients 
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No. with data 154 162
Mean — yr 26.4±8.7 26.1±8.7
Male sex — no. (%) 130 (84.4) 142 (87.7)
Height
No. with data 141 154
Mean — cm 176.6±9.4 179.5±8.9
Weight
No. with data 142 154
Mean — kg 67.0±13.2 68.6±13.1
Body‑mass index†
No. with data 141 153
Mean 21.4±3.7 21.3±3.5
Symptom duration
No. with data 153 160
Mean — hr 44.5±90.3 33.8±61.3
Pneumothorax size
No. with data 154 162
Mean — % of lung according to Collins formula 67.5±22.6 63.6±23.4
Pneumothorax on right side — no. (%) 88 (57.1) 89 (54.9)
Heart rate
No. with data 132 149
Mean — beats per min 73.3±11.9 77.5±14.4
Systolic blood pressure
No. with data 134 148
Mean — mm Hg 117.8±13.2 119.8±13.1
Respiratory rate
No. with data 134 144
Mean — breaths per min 17.0±2.6 16.9±3.3
Oxygen saturation
No. with data 134 148
Mean — % 97.6±1.6 97.2±2.0
Chest‑pain score‡
No. with data 119 138
Mean 2.4±2.2 2.1±2.1
Borg dyspnea index§
No. with data 112 133
Mean 1.2±1.2 1.7±1.4
Pack‑yr of tobacco smoking
No. with data 141 145
Mean 8.1±23.3 4.8±7.8
Smoking history — no./total no. (%)
Current 75/152 (49.3) 68/160 (42.5)
Past 19/152 (12.5) 16/160 (10.0)
Never 58/152 (38.2) 76/160 (47.5)
*  Plus–minus values are means ±SD.
†  The body‑mass index is the weight in kilograms divided by the square of the height in meters.
‡  A score of 0 indicated no chest pain, 5 moderate pain, and 10 the worst possible pain.
§  The Borg dyspnea index measures perceived breathlessness on a scale from 0 (none) to 10 (maximum).
Table 1. Characteristics of the Patients at Baseline.*
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(91.9%) in the intervention group and 109 of 
115 (94.8%) in the conservative-management 
group as having resolution, whereas clinicians 
assessed 123 of 124 patients (99.2%) in the in-
tervention group and 114 of 115 (99.1%) in the 
conservative-management group as having res-
olution.
Symptom Resolution
Complete resolution of symptoms by 8 weeks 
was reported in 128 of 137 patients (93.4%) in 
the intervention group and in 139 of 147 (94.6%) 
in the conservative-management group (risk 
difference, 1.1 percentage points; 95% CI, −4.4 
to 6.7). The time until symptom resolution did 
not differ substantially between the two groups, 
with a median time of 15.5 days (95% CI, 12 to 
23) in the intervention group and 14.0 days 
(95% CI, 12 to 19) in the conservative-manage-
ment group (hazard ratio, 1.11; 95% CI, 0.88 to 
1.40) (Fig. S5).
Recurrence
Recurrence during the first 12 months was 
more frequent in the intervention group than in 
the conservative-management group: 25 of 149 
patients (16.8%) as compared with 14 of 159 
(8.8%) (absolute risk difference, 8.0 percentage 
points; 95% CI, 0.5 to 15.4) (Table 2). The time 
until pneumothorax recurrence during the first 
12 months was longer in the conservative-
management group than in the intervention 
group (hazard ratio, 0.59; 95% CI, 0.34 to 1.02) 
(Fig. S6).
Adverse Events
A total of 41 patients in the intervention group 








Relative Risk  
(95% CI)
Risk Difference  
(95% CI)†
One or more procedures — no. (%) 145 (94.2) 25 (15.4) 6.10 (4.24–8.77) 78.1 (72.0–85.4)
Chest drainage for ≥72 hr — no./total no. (%) 78/153 (51.0) 15/162 (9.3) 5.51 (3.32–9.14) 41.7 (32.6–50.8)
Suction — no. (%) 52 (33.8) 12 (7.4) 4.56 (2.53–8.20) 26.4 (17.9–34.9)
At least one CT scan — no./total no. (%) 28/146 (19.2) 12/154 (7.8) 2.46 (1.31–4.66) 11.4 (3.7–19.1)
Hospital revisit — no. (%) 41 (26.6) 28 (17.3) 1.54 (1.01–2.36) 9.3 (0.3–18.4)
Any adverse event — no. (%) 41 (26.6) 13 (8.0) 3.32 (1.85–5.95) 18.6 (10.5–26.7)
Any serious adverse event — no. (%) 19 (12.3) 6 (3.7) 3.30 (1.37–8.10) 8.6 (2.7–14.6)
Pneumothorax recurrence within 12 mo — 
no./total no. (%)
25/149 (16.8) 14/159 (8.8) 1.90 (1.03–3.52) 8.0 (0.5–15.4)
No. of chest radiographs per patient 10.9±7.1 6.4±3.9 1.7 (1.6–1.8)‡ 4.5 (3.2–5.8)§
No. of surgical procedures per patient¶ 0.3±0.5 0.1±0.2 4.21 (2.10–8.41)‡
Length of hospital stay in first 8 wk — days
Mean 6.1±7.6 1.6±3.5 2.8 (1.8–3.6)‖
Median (IQR) 3.8 (0.8–9.3) 0.2 (0.2–0.8)
Days off from work
Mean 10.9±12.7 6.0±7.3 2.0 (1.0–3.0)‖
Median (IQR) 6.0 (2.0–14.0) 3.0 (1.0–8.0)
*  Plus–minus values are means ±SD. CT denotes computed tomographic, and IQR interquartile range.
†  Shown is the risk difference between the intervention group and the conservative‑management group, as measured in percentage points, 
unless otherwise indicated.
‡  Shown is the relative rate.
§  Shown is the mean difference in the number of chest radiographs.
¶  In the intervention group, 34 video‑assisted thoracic surgeries were performed in 33 patients and 6 thoracotomies were performed in 6 pa‑
tients. In the conservative‑management group, 10 video‑assisted thoracic surgeries were performed in 10 patients.
‖  Shown is the Hodges–Lehmann location shift for the intervention group minus the conservative‑management group.
Table 2. Secondary Outcomes.*
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had at least one adverse event (relative risk, 
3.32; 95% CI, 1.85 to 5.95); 19 patients in the 
intervention group and 6 in the conservative-
management group had a serious adverse event 
(relative risk, 3.30; 95% CI, 1.37 to 8.10) (Tables 
2 and 3). Most adverse events in both groups 
were directly attributable to either insertion of 
the chest tube or having the tube in place. One 
death occurred in the conservative-management 
group by suicide at a time when the pneumo-
thorax had resolved.
Other Secondary Outcomes
The chest tube remained in place for 72 hours 
or more in 78 patients in the intervention group 
and in 15 patients in the conservative-manage-
ment group (relative risk, 5.51; 95% CI, 3.32 to 
9.14), and suction was performed in 52 patients 
in the intervention group and in 12 patients in 
the conservative-management group (relative risk, 
4.56; 95% CI, 2.53 to 8.20) (Table 2 and Table 
S4). The relative rate of progression to surgery 
in the intervention group as compared with the 
conservative-management group was 4.21 (95% 
CI, 2.10 to 8.41) (Table 2). The mean (±SD) 
length of hospital stay in the first 8 weeks for 
patients in the intervention group was 6.1±7.6 
days, with a mean of 10.9±12.7 days off from 
work in the same period, as compared with 
1.6±3.5 days and 6.0±7.3 days, respectively, for 
patients in the conservative-management group 
(Hodges–Lehmann location shift [intervention 
group minus conservative-management group], 
2.8 [95% CI, 1.8 to 3.6] for length of hospital 
stay and 2.0 [95% CI, 1.0 to 3.0] for days off 
from work) (Table 2 and Tables S5 and S7). The 
odds ratio for satisfaction with interventional 
management as compared with conservative 
management was 0.68 (95% CI, 0.43 to 1.07), 
with a lower odds ratio consistent with less sat-
isfaction with interventional management. There 
was no evidence of treatment-effect modification 
(interaction) according to prespecified subgroups 
defined by age, clinician-estimated size of pneu-
mothorax, symptom duration, or smoking sta-
tus (Table S8).
Discussion
This randomized, controlled trial of conservative 
as compared with interventional management of 
moderate-to-large primary spontaneous pneumo-
thorax provides modest, but statistically fragile, 
evidence that conservative management was non-
inferior to interventional management for ra-
diographic resolution within 8 weeks, with the 
use of a 9-percentage-point margin; the time 
until complete resolution of symptoms did not 
differ substantially between the two approaches. 
Conservative management spared 85% of the 
patients from an invasive intervention and re-
sulted in fewer hospitalization days, a lower 
likelihood of prolonged chest-tube drainage, 
less need for surgery, and fewer adverse events 
and serious adverse events than interventional 
management. The percentage of patients with 
early pneumothorax recurrence was also lower 
in the conservative-management group.
Our trial challenges the fundamental concept 
of whether initial routine drainage is required in 
all patients with primary spontaneous pneumo-
thorax. It was conducted at 39 centers across a 
spectrum of rural, urban, secondary, and ter-
tiary health care settings, and after a standard-
ized initial approach to randomized treatment, 
subsequent interventions were undertaken by 
treating clinicians as per their usual practice. 
Only patients with moderate-to-large primary 
spontaneous pneumothorax, for which most 
clinicians would intervene, were included. Re-
cruitment was limited to those with a first epi-
sode of primary spontaneous pneumothorax 
(on the affected side) to avoid the confounding 
effects of previous treatments. The age range of 
14 to 50 years reduced the likelihood that pa-
tients with secondary pneumothorax would be 
included.
Our trial has several limitations. It was not 
possible to mask trial-group assignments to 
patients or clinicians. Treating clinicians were 
more likely than the independent radiologists 
who were unaware of the trial-group assign-
ments to report full radiographic resolution in 
the group receiving interventional management, 
which biased the primary-outcome findings in 
favor of interventional treatment. Although we 
used multiple radiographic examinations to iden-
tify pneumothorax recurrence, it is possible that 
some episodes of recurrence may have been 
missed, and there may have been different thresh-
olds for presentation with recurrent symptoms 
between the two groups. Conservative manage-
ment was associated with fewer pneumothorax 
recurrences than interventional management, 
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with divergence in the frequency of recurrence 
occurring during the first 3 months after initial 
presentation with primary spontaneous pneumo-
thorax. Some of these early recurrences may 
have represented an ongoing slow leak despite 
initial reinflation or may have been due to rapid 
expansion of the lung (and hence the visceral 
pleural wound), with or without the use of suc-
tion, resulting in physical impairment of heal-
ing — contrary to the view that adhesions may 
form between the visceral pleura and the pari-
etal pleura if the lung is reexpanded.
A major limitation was that the original sta-
tistical analysis plan did not specify the win-
dow for the 8-week visit nor define how miss-
ing radiographic data were to be handled for 
the primary outcome. These issues were impor-
tant, because 22 patients who did not have 
resolution at their 4-week visit had resolution at 
the time of their scheduled 8-week visit, which 
occurred after 56 days. Although this issue was 
addressed by treating data for the primary out-
come as missing in patients in whom the 
8-week visit occurred after 56 days and by un-
dertaking two sensitivity analyses to help de-
termine the effects of informative censoring 
and treating of missing data as treatment fail-
ure, these approaches resulted in statistical fra-
gility and need to be considered exploratory. In 
the sensitivity analysis in which all missing data 
were imputed as failure, the risk difference for 
radiographic resolution at 56 days in the con-
servative-management group was −11 percent-
age points, with a lower boundary of the 95% 
confidence interval of −18 percentage points. 
However, the median time until symptom reso-
lution (approximately 2 weeks) was similar in 
the two groups, and a small residual pneumo-
thorax is likely to be clinically significant only 
in the context of air travel. Secondary analyses 
have not been adjusted for multiple compari-
sons and should not be used to infer definitive 
treatment effects.
This trial provides modest evidence that con-
servative management was noninferior to inter-
ventional management for radiographic resolu-
tion of moderate-to-large primary spontaneous 
pneumothorax within 8 weeks. Conservative 
management spared 85% of the patients from an 
invasive intervention and incurred fewer days in 
the hospital or off from work, lower rates of sur-









Total adverse events* 49 16
Predefined adverse events




Skin infection 3§ 1
Unknown site 1‡ 0
Tension pneumothorax¶ 2 1
Other adverse events
Severe chest pain or breathlessness 11 4
Surgical emphysema 6 0
Lung collapse after removal of chest tube 6‖ 0
Persistent cough 2 0
Hypotension or altered conscious state 
related to procedure
2 0
Reexpansion pulmonary edema 2 0
Equipment disconnection 2 0
Topical skin reaction to chlorhexidine 1 0
Other 4** 4††
*  A total of 49 adverse events occurred in 41 patients in the intervention 
group and 16 in 13 patients in the conservative‑management group. Serious 
adverse events (defined as those that resulted in prolonged hospitalization, 
life‑threatening or fatal illness, or intervention to prevent these outcomes) 
occurred in 19 patients in the intervention group and 6 in the conservative‑
management group.
†  The three instances of hemothorax in the conservative‑management group 
were noted as a pleural effusion on the chest radiograph, before insertion of 
any chest tube. An additional hemothorax was associated with the tension 
pneumothorax reported in the conservative‑management group.
‡  The case of empyema in the conservative‑management group and the infec‑
tion of unknown site in the intervention group were associated with sepsis.
§  One of the three skin infections in the intervention group was associated 
with sepsis.
¶  Three cases of tension pneumothorax were reported, one in the conserva‑
tive‑management group (the patient presented again for care 30 hours after 
initial discharge) and two in the intervention group (one patient had an in‑
crease in pneumothorax size while an inpatient that was attributed to a 
kinked chest tube, and the other presented 4 days after initial discharge);  
all resolved promptly with insertion or adjustment of the chest tube.
‖  One case was managed conservatively, and five cases were managed with 
reinsertion of the chest tube with or without video‑assisted thoracoscopic 
pleurodesis.
**  There was one case each of bleeding around the site of the chest tube, agi‑
tation, numbness around the site of the chest tube, and patient self‑dis‑
charge with the drain in place.
††  There was one case each of Horner’s syndrome after insertion of the chest 
tube, death by suicide (unrelated to the trial), nausea and dizziness, and ex‑
cessive scar tissue around the site of the chest tube.
Table 3. Adverse Events (Intention-to-Treat Analysis).
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or pneumothorax recurrence than interventional 
management.
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